Tyler Wiechman

By Tyler Wiechman Wiechman currently works in the cardiovascular specialty of a privately owned pharmaceutical company working with specialists and hospitals in the Central Pennsylvania Region. He withdrew from a PhD in biomedical sciences from the Penn State University Hershey College of Medicine and received his BS in Psychology from the University of Delaware in 2011. He has worked for three different labs focusing on Neurological/Psychological health and behavior. Aspiring medical scientists face increasing pressure as they aim to eradicate a disease state, find a new genetic marker for cancer or any number of neurological diseases, or create the next clinically sound pharmaceutical...
By Tyler Wiechman Wiechman currently works in the cardiovascular specialty of a privately owned pharmaceutical company working with specialists and hospitals in the Central Pennsylvania Region. He withdrew from a PhD in biomedical sciences from the Penn State University Hershey College of Medicine and received his BS in Psychology from the University of Delaware in 2011. He has worked for three different labs focusing on Neurological/Psychological health and behavior. Aspiring medical scientists face increasing pressure as they aim to eradicate a disease state, find a new genetic marker for cancer or any number of neurological diseases, or create the next clinically sound pharmaceutical...

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter